CompletedNot applicableNCT01702987
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
Studying Mitochondrial myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beth Israel Deaconess Medical Center
- Principal Investigator
- Jim S Wu, MDBeth Israel Deaconess
- Intervention
- ubiquinol(dietary_supplement)
- Enrollment
- 22 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2012 – 2013
Study locations (1)
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01702987 on ClinicalTrials.govOther trials for Mitochondrial myopathy
Additional recruiting or active studies for the same condition.